Osteoporosis Medication Effects on Spine Bone Quality
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study tests how a bone-strengthening medication called Abaloparatide affects the quality of bones in your lower spine. Researchers will use imaging scans to see if the medication helps improve bone strength in people with osteoporosis who also have spine wear-and-tear.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with osteoporosis (either from a fragility fracture, low bone density score, or high fracture risk)
- Have wear-and-tear disease in your lower spine (spondylosis, disc disease, stenosis, or scoliosis)
- Qualify for treatment with an anabolic bone medication based on clinical guidelines
- Never had surgery on your lower spine
- Willing to have three imaging scans (DEXA, MRI, and CT) within 3 months of starting the medication
- No history of bone cancer, Paget disease, kidney disease causing high calcium, or prior radiation therapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a daily injection called abaloparatide, which helps strengthen bones and reduce the chance of breaking a bone. It is for postmenopausal women with osteoporosis who are at higher risk of fractures.
This study tests a new version of a medicine called abaloparatide (used for bone health) to see if it works the same as the approved version (Tymlos). It is for healthy adults aged 40–65 who are willing to stay at the clinic for a few days and have blood tests.
This trial tests teriparatide (a hormone-like bone medicine) to improve bone health in people with advanced chronic kidney disease who are at risk for weak, low-turnover bone. It may help by changing how quickly your bones break down and rebuild.
This study tests a new classification system to help doctors decide the best treatment for spine fractures caused by osteoporosis. It aims to improve pain and mobility by matching treatment to fracture type.
This study looks at ways to prevent and treat “brittle bone” refractures after a recent fracture in people with osteoporosis. If you’ve had a new hip, spine, or other bone fracture, the trial may test strategies to lower the chance of another fracture.
This study tests whether an osteoporosis medication can help preserve muscle strength in older adults who live in senior facilities. It's for people age 65+ with fragile bones or low bone density who are at risk for falls and fractures.
Hear when a new Lumbar Degenerative Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.